← Back to headlines
New Novo Nordisk Weight-Loss Drug Shows Promising Results in China
A Chinese study of a new triple agonist weight-loss drug under development by Novo Nordisk has shown significant weight loss of up to 19.7 percent.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
seeking-alphaSerbian166d ago
Novo’s China obesity drug posts positive mid-stage trial results
Read full article →berlingskeDanish166d ago
Nyt Novo-middel viser vægttab på op til 19,7 procent i Kina
Et kinesisk studie af en såkaldt triple agonist, som er under udvikling, viser vægttab på op mod 20 procent.
Read full article →Coverage Timeline
First report: berlingske · 24 Feb, 10:13|Full coverage: 2 · 39m|Window: 39m
Left-leaningCenterRight-leaning
